FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Clinical trials for FEMALE REPRODUCTIVE SYSTEM NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new FEMALE REPRODUCTIVE SYSTEM NEOPLASM trials appear
Sign up with your email to follow new studies for FEMALE REPRODUCTIVE SYSTEM NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo takes on rare cancers: hope for patients with few options
Disease control OngoingThis study tests a combination of two immunotherapy drugs, ipilimumab and nivolumab, in people with rare cancers that are known to respond to immunotherapy. The cancers include certain neuroendocrine tumors, biliary tract cancers, gynecological cancers, and mismatch repair defici…
Matched conditions: FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: PHASE2 • Sponsor: Olivia Newton-John Cancer Research Institute • Aim: Disease control
Last updated May 17, 2026 03:18 UTC
-
Cancer fear study pulled before starting
Knowledge-focused TerminatedThis study was designed to see if an online mental health program could help women with advanced gynecologic or breast cancer manage their fear of the cancer returning or getting worse. The program would have been compared to standard educational materials. However, the trial was…
Matched conditions: FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated May 14, 2026 12:01 UTC
-
Can a website help cancer patients protect their fertility?
Knowledge-focused OngoingThis study looks at whether a special website can help women with cancer make better decisions about preserving their ability to have children after treatment. About 130 women with certain cancers (like breast or lymphoma) will use the website or get usual care. The goal is to se…
Matched conditions: FEMALE REPRODUCTIVE SYSTEM NEOPLASM
Phase: NA • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC